35 -5 (37) 2021 — Kazakov B.Sh. — MORPHOFUNCTIONAL FACTORS LEADING TO INDIVIDUAL FORMATION OF COVID-19-ASSOCIATED ISCHEMIC STROKE

MORPHOFUNCTIONAL FACTORS LEADING TO INDIVIDUAL FORMATION OF COVID-19-ASSOCIATED ISCHEMIC STROKE

Kazakov B.Sh. Bukhara State Medical Institute

Resume

 Stroke is now one of the leading causes of disability, affecting a person’s movement, intuition and other psycho-emotional appearance. By the end of the acute period of stroke in 85% of patients who survived a stroke, movement disorders, speech disorders (aphasia) are observed. In some patients with COVID-19, acute stroke is reversible due to morphofunctional changes in the brain. This article analyzes this very scientific issue.

Keywords: COVID-19, coronavirus patients, morphofunctional changes, stroke, nerve cell, complication.

First page

122

Last page

124

For citation: Kazakov B.Sh. MORPHOFUNCTIONAL FACTORS LEADING TO INDIVIDUAL FORMATION OF COVID-19-ASSOCIATED ISCHEMIC STROKE //New Day in Medicine 5(37)2021 122-124 https://cutt.ly/wT8xC0p

LIST OF REFERENCES:

1. Grabowska-Fudala B., Jaracz K., Gуrna K. Stroke incidence, case fatality and mortality–current trends and future prognosis // Przegl. Epidemiol. — 2010. — №3. — Р. 439-442.
2. Hassoun H.T., Malas M.B., Freischlag J.A. Secondary stroke prevention in the era of carotid stenting: update on recent trials // Arch. Surg. — 2010. — №10. — Р.928-935.
3. Kaste M. Every day is a world stroke day: act now, be a stroke champion and a torchbearer // Stroke. — 2010. — №11. — Р. 2449-2250.
4. Аст Now. Impementation guidelines for stroke management. — 2010.
5. Goldstein L.B., Bushnell C.D., Adams R.J. et al. Guidelines for the primary prevention of stroke. A guideline for health­care professionals from the American Heart Association // Stroke. — 2010.
6. Yarygin K.N., Kholodenko I.V., Konieva A.A. et al. Mechanisms of positive effects of transplantation of human placental mesenchymal stem cells on recovery of rats after experimental ischemic stroke // Bull. Exp. Biol. Med. — 2009. — Vol. 148. — P. 862-868.
7. Kadirovna K. D., Tajiyevna K. D., Shodiyorovich K. B. Clinical and neurological factors in the formation of individual predisposition to covid-associated ischemic stroke //International Engineering Journal For Research & Development. – 2020. – Т. 5. – №. SPECIAL ISSUE. – С. 4-4.
8. Ostrovaya T.V., Cherniy V.I. Cerebroprotection in the aspect of evidence-based medicine // Medicine of emergency conditions. – 2007. – No. 2. – S. 48-53.
9. Shodiyorovich K. B., Tadjiyevna K. D. Clinical rehabilitation of patients with cerebral stroke caused by a stroke with COVID-19 //European Journal of Molecular & Clinical Medicine. – 2021. – Т. 8. – №. 1. – С. 1446-1451.
10. Ginsberg M.D. Adventures in pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection. The Thomas Willis lecture // Stroke. — 2003. — №1. — Р. 214-223.
11. Cherniy V.I., Elskiy V.N., Gorodnik G.A. et al. Acute cerebral insufficiency. – Donetsk: Izd. Zaslavsky A.Yu., 2008 . – 440 p.
12. Shtark MB Brain-specific proteins (antigens) and neuron function. – M.: Medicine, 1989.
13. Kong D.F., Topol E.J., Bittl J.A. et al. Clinical outcomes of bivalirudin for ischemic heart disease // Circulation. — 1999. — №100. – Р. 2049-2053.